Drug Discovery · South San Francisco, CA · Founded 2023 · Privately Held (backing)
Operator of a heart health company intended to modernize cardiovascular drug development. Kardigan is based in South San Francisco, CA and was founded in 2023. It is valued at about $646 million as of Oct 2026, set by institutional fund marks. It has raised $554 million across 1 recorded round; the latest was a $254 million Series B in Oct 2025.
PMV mark · valuation
$646.0M
Oct 2026
Priced at
—
Total raised
$554.0M
Last round
Early Stage VC (Series B)
Oct 2025
Cap table — not yet on record
Kardigan's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.